SecondWave Systems
Wearable ultrasound for inflammation
SecondWave Systems develops a noninvasive, wearable ultrasound stimulation platform for therapeutic applications. It uses ultrasound to modulate nerves, cells, and organs for treating inflammation, pain, and other disorders.
Source: HealthTechAlpha
HealthTechAlpha provided this information. To learn more and get deep data on all digital health companies, please visit them here.
Visit HealthTechAlpha →How We Help
Problem Statement
Inflammation, pain, and other disorders require effective therapeutic solutions through nerve, cell, and organ modulation.
Core Technology
noninvasive, wearable ultrasound stimulation platform with proprietary sensing/imaging for adaptive, personalized therapy
Key Differentiators
Noninvasive ultrasound delivery mechanism; Miniaturized wearable form factor suitable for home use; Proprietary sensing/imaging for adaptive, personalized therapy
Clinical Focus
Therapeutic applications; Nerve modulation; Cell modulation; Organ modulation
Company Info
- Business Model
- Device Sales
- Founded
- 2019
- Total Funding
- 7,000,000
- Website
- www.secondwaveus.com
Categories
Technologies
Clinical & IP
Clinical Validation
Pilot ULTRA study: 13 RA patients, 10/13 showed benefit, >66% significant disease activity reduction. No serious adverse events. Positive Long COVID results from 100+ patient studies. Advancing to randomized controlled trial.
MedStartr Index Score
?What do you think of SecondWave Systems?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.